ArticleJournal of nanobiotechnology2022

Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma.

Jiejian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.